| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $72K | +0.0% |
| Cost of Revenue | $6K | +0.0% |
| Gross Profit | $66K | +0.0% |
| R&D Expense | $2.4M | +180.2% |
| Operating Income | -$4.7M | -22.0% |
| Pre-tax Income | -$4.4M | -21.0% |
| Net Income | -$4.4M | -18.7% |
| EPS (Basic) | -$1.19 | +0.8% |
| EPS (Diluted) | -$1.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | +10.8% |
| Short-term Investments | $3.2M | -23.3% |
| Current Assets | $7.1M | -7.4% |
| Total Assets | $7.4M | -4.3% |
| Current Liabilities | $1.7M | +113.5% |
| Total Liabilities | $2.4M | +51.5% |
| Stockholders' Equity | $5.0M | -18.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | -18.9% |
| Investing Cash Flow | $974K | +123.5% |
| Financing Cash Flow | $3.2M | +788.1% |
| +0.8% |